[at noodls] – App Provides Immediate Access to Company News and Financial Information EMERYVILLE, CA – January 15, 2013 – NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology company focused on addressing … moreView todays social media effects on NBYView the latest stocks trending across Twitter. Click to view dashboardSee who NovaBay is hiring next, click here to view […]
[at noodls] – Phase 2b BAYnovation Study for the Treatment of Viral Conjunctivitis Includes 60 Clinical Sites Worldwide EMERYVILLE, CA – January 3, 2013 – NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology … moreView todays social media effects on NBYView the latest stocks trending across Twitter. Click to view dashboardSee who NovaBay is hiring next, click here to view […]
[at noodls] – Recent $7 Million Financing to Accelerate and Expand Clinical Trials Steady Progress Across Four Business Units: Ophthalmology • Viral conjunctivitis (unmet medical need) – Financing to accelerate Phase … moreView todays social media effects on NBYView the latest stocks trending across Twitter. Click to view dashboardSee who NovaBay is hiring next, click here to view […]
[at noodls] – EMERYVILLE, Calif., Dec. 5, 2012 (GLOBE NEWSWIRE) — NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective … moreView todays social media effects on NBYView the latest stocks trending across Twitter. Click to view dashboardSee who NovaBay is hiring next, click here to view […]
[at noodls] – EMERYVILLE, Calif., Dec. 6, 2012 (GLOBE NEWSWIRE) — NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective … moreView todays social media effects on NBYView the latest stocks trending across Twitter. Click to view dashboardSee who NovaBay is hiring next, click here to view […]
[at noodls] – EMERYVILLE, CA – November 28, 2012 – NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market … moreView todays social media effects on NBYView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – NovaBay receives additional $1.5M equity funding from Pioneer Pharma EMERYVILLE, CA – Novemeber 5, 2012 – NovaBay Pharmaceuticals announced the receipt of a $1.5M equity investment from Pioneer Pharma … moreView todays social media effects on NBYView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – NovaBay Pharmaceuticals Provides Third Quarter 2012 Financial Results Enrollment Continues to Advance in Three Phase 2b Clinical Trials for Conjunctivitis, Impetigo and UCBE Recent Highlights Global Phase … moreView todays social media effects on NBYView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – NovaBay Pharmaceuticals to Present at Lazard Capital Markets 9th Annual Healthcare Conference EMERYVILLE, CA – October 31, 2012 – NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biotechnology company … moreView todays social media effects on NBYView the latest stocks trending across Twitter. Click to view dashboard […]
